Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Volpi

Showing results (141-150 of 192) with videos related to

Pageof 20
Sort By:
Tumori|April 30, 1988
Radioligand-labeled binding assay and immunochemical assay for estrogen receptor in 115 human breast cancersA Riccobon, W Zoli, A Capucci, et al.
International Journal of Cancer|March 17, 2000
Tumor microvessel density and prognosis in node-negative breast cancerL Medri, O Nanni, A Volpi, et al.
Contributions to Nephrology|January 1, 1991
Clinical outcome and follow-up of patients with renal damage in microscopic polyarteritis. Personal dataN Saporiti, M Meroni, A Sessa, et al.
The Journal of Nuclear Medicine and Allied Sciences|October 1, 1990
[Relationship between cytosol CEA and clinico-pathologic and biologic parameters in 167 cases if primary carcinoma of the breast]A Riccobon, L Frassineti, M Vasini, et al.
Contributions to Nephrology|January 1, 1993
Glomerulonephritis in the elderly aged over 65. Clinicopathological analysis of 92 patientsA Sessa, M Meroni, G Battini, et al.
Cancer|January 1, 1993
Cell kinetics and prognosis in gastric cancerD Amadori, C Bonaguri, A Volpi, et al.
American Journal of Nephrology|January 1, 1988
Postinfectious glomerulonephritis in the elderlyA Volpi, M Meroni, G Battini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2002
Current treatments and perceptions of genital herpes: a European-wide viewA Strand, S Barton, A Alomar, et al.
Urologia|November 19, 2010
[Investigational drug therapies for overactive bladder syndrome: the potential alternatives to anticolinergics]E Sacco, F Pinto, D Tienforti, et al.
Infection|June 16, 2011
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistanceC Sarrecchia, V Svicher, A Volpi, et al.
Pageof 20

Showing results (141-150 of 192) with videos related to

Sort By:
Pageof 20
Tumori|April 30, 1988
Radioligand-labeled binding assay and immunochemical assay for estrogen receptor in 115 human breast cancersA Riccobon, W Zoli, A Capucci, et al.
International Journal of Cancer|March 17, 2000
Tumor microvessel density and prognosis in node-negative breast cancerL Medri, O Nanni, A Volpi, et al.
Contributions to Nephrology|January 1, 1991
Clinical outcome and follow-up of patients with renal damage in microscopic polyarteritis. Personal dataN Saporiti, M Meroni, A Sessa, et al.
The Journal of Nuclear Medicine and Allied Sciences|October 1, 1990
[Relationship between cytosol CEA and clinico-pathologic and biologic parameters in 167 cases if primary carcinoma of the breast]A Riccobon, L Frassineti, M Vasini, et al.
Contributions to Nephrology|January 1, 1993
Glomerulonephritis in the elderly aged over 65. Clinicopathological analysis of 92 patientsA Sessa, M Meroni, G Battini, et al.
Cancer|January 1, 1993
Cell kinetics and prognosis in gastric cancerD Amadori, C Bonaguri, A Volpi, et al.
American Journal of Nephrology|January 1, 1988
Postinfectious glomerulonephritis in the elderlyA Volpi, M Meroni, G Battini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2002
Current treatments and perceptions of genital herpes: a European-wide viewA Strand, S Barton, A Alomar, et al.
Urologia|November 19, 2010
[Investigational drug therapies for overactive bladder syndrome: the potential alternatives to anticolinergics]E Sacco, F Pinto, D Tienforti, et al.
Infection|June 16, 2011
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistanceC Sarrecchia, V Svicher, A Volpi, et al.
Pageof 20